Total amount: € 0,00
HOW TO ORDER
THE JOURNAL OF CARDIOVASCULAR SURGERY
A Journal on Cardiac, Vascular and Thoracic Surgery
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,632
ORIGINAL ARTICLES CARDIAC SECTION
The Journal of Cardiovascular Surgery 2005 December;46(6):551-7
The supportive value of pre-bypass L-Glutamate loading in patients undergoing coronary artery bypass grafting
Bitzikas G. 1, Papakonstantinou C. 1, Lazou A. 2, Bougioukas G. 1, Toumpouras M. 1, Tripsianis G. 3, Spanos P. 1
1 Department of Cardiothoracic Surgery AHEPA Hospital, Aristotles University of Thessaloniki Thessaloniki, Greece
2 Department of Biology Aristotles University of Thessaloniki Thessaloniki, Greece
3 Department of Biostatistics Democritus University of Thrace Alexandroupolis, Greece
Aim. Experimental studies have demonstrated that an exogenous supply of glutamate improves mechanical function and recovery of ischemic myocardium. The aim of the present study was to investigate the effect of myocardial pre-bypass loading with glutamate on myocardial protection during global ischemia and reperfusion of patients undergoing coronary artery bypass grafting (CABG).
Methods. The study was double blinded. Twenty patients undergoing elective CABG were randomized to receive L-glutamate (n=10) or normal saline (n=10). Intracellular levels of glutamate, ATP and lactate were measured in left ventricular biopsies collected 10 min after aortic clamp release. Hemodynamic data, and postoperative release of CK-MB and troponin T were also measured.
Results. Pre-bypass administration of glutamate resulted in myocardial glutamate loading since glutamate levels were significantly higher in the glutamate group of patients than in controls (18.6 ± 3.1 versus 8.7 ± 1.2 μg/g tissue, P<0.001). In the same group ATP levels were also significantly higher (2.4 ± 0.7 versus 1.5 ± 0.4 μg/g tissue, P<0.05) and lactate levels significantly less than in controls (6.9 ± 1.9 versus 12.0 ± 2.1 μg/g tissue, P<0.001). Glutamate patients had statistically significantly superior post-bypass hemodynamic performance (cardiac index, left ventricular stroke work index, systemic vascular resistance and pulmonary vascular resistance). Statistically significantly lower levels of CK-MB (6 h postoperative), total and peak CK-MB, troponin T (24 h postoperative), and total troponin T were found in the glutamate group.
Conclusion. The results of this preliminary study indicate that pre-bypass intravenous administration of glutamate in patients undergoing CABG has a supportive effect on myocardial metabolism during global ischemia and reperfusion, improves patients’ postoperative hemodynamic performance and reduces postoperative cardiac enzyme release.